Cytek Biosciences Inc (CTKB) Inventory Turnover Ratio, from first quarter 2026 to first quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket
 
Cytek Biosciences Inc   (NASDAQ: CTKB)
 

Cytek Biosciences Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the first quarter 2026, Cytek Biosciences Inc 's inventory turnover ratio sequentially decreased to 1.96 in the first quarter 2026, otherwise the ratio remained above the average, as CTKB's markets remain strong.Cytek Biosciences Inc 's average inventory processing period in the Mar 31 2026 quarter, has increased to 186 days, from 183 days, in the Dec 31 2025 quarter.

Within Healthcare sector 208 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2026, to 920, from total ranking in the fourth quarter 2025 at 1117.

CTKB Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Cytek Biosciences Inc Market Share?

What is Inventory Turnover Ratio?




CTKB Inventory Turnover Ratio (Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
(Mar 31 2025)
I. Quarter
Y / Y Inventory Growth 9.8 % 10.33 % 10.36 % -1.16 % -17.16 %
Y / Y Cost of Sales Growth 4.76 % 20 % 9.09 % 3.5 % 0 %
Inventory Turnover Ratio (TTM) 1.96 1.99 1.93 1.93 1.91
CTKB's Total Ranking # 920 # 1117 # 985 # 1166 #
Average inventory processing period 186 184 189 189 191
Seq. Inventory Growth 2.81 % -6.24 % 4.37 % 9.13 % 3.31 %
Seq. Cost of Sales Growth -26.67 % 25 % 10.42 % 3.5 % -16 %




Inventory Turnover Ratio Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 9
Healthcare Sector # 209
Overall Market # 920

Inventory Turnover Ratio Statistics
High Average Low
1.99 1.62 1.2
(Dec 31 2025)   (Jun 30 2023)




Financial Statements
Cytek Biosciences Inc 's Inventories $ 50 Millions Visit CTKB's Balance sheet
Cytek Biosciences Inc 's Cost of Revenues TTM $ 98 Millions Visit CTKB's Income Statement
What are CTKB's Sales? Visit CTKB's Sales by Segment

Other Inventory Turnover Ratios
Cytek Biosciences Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Laboratory Analytical Instruments Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
CTKB's Inventory Turnover Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for CTKB's Competitors
Inventory Turnover Ratio for CTKB's Suppliers
Inventory Turnover Ratio for CTKB's Customers

You may also want to know
CTKB's Sales Growth Rates CTKB's Pe Price to earnings ratio CTKB's Receivables Turnover Ratio CTKB's Stock Quote
CTKB's Net Income Growth Rates CTKB's Ps Price to Sales ratio CTKB's Sales per Employee CTKB's Asset Turnover Ratio
CTKB's Net Margin CTKB's Pb Price to Book ratio CTKB's Financial Strength Ratios CTKB's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2026 Inventories at quarter ending Mar 31 2026
Steris Plc  5.27 $ 3,309.400  Millions$ 628  Millions
Bristol myers Squibb Company  5.24 $ 14,324.000  Millions$ 2,735  Millions
Harrow Inc   5.11 $ 69.568  Millions$ 14  Millions
Integer Holdings Corporation  5.11 $ 1,365.000  Millions$ 267  Millions
Tactile Systems Technology Inc   5.08 $ 81.000  Millions$ 16  Millions
Integrated Biopharma Inc  4.96 $ 45.000  Millions$ 9  Millions
Ufp Technologies Inc   4.95 $ 436.000  Millions$ 88  Millions
Polomar Health Services, Inc.  4.79 $ 0.642  Millions$ 0  Millions
Henry Schein Inc   4.70 $ 9,209.000  Millions$ 1,959  Millions
Bionexus Gene Lab Corp   4.70 $ 4.191  Millions$ 1  Millions
Medinotec Inc   4.69 $ 4.864  Millions$ 1  Millions
West Pharmaceutical Services Inc   4.68 $ 2,052.000  Millions$ 439  Millions
Scilex Holding Company  4.48 $ 14.462  Millions$ 3  Millions
Guardant Health Inc   4.41 $ 379.203  Millions$ 86  Millions
Idexx Laboratories Inc  4.38 $ 1,690.942  Millions$ 386  Millions
Envista Holdings Corporation  4.36 $ 1,267.000  Millions$ 290  Millions
Inotiv Inc   4.25 $ 175.895  Millions$ 41  Millions
Cryoport inc   4.23 $ 96.609  Millions$ 23  Millions
Teva Pharmaceutical Industries Limited  4.22 $ 8,317.000  Millions$ 1,971  Millions
Incyte Corporation  4.21 $ 403.465  Millions$ 96  Millions
Electromed Inc   4.16 $ 14.195  Millions$ 3  Millions
Vericel Corporation  4.15 $ 73.494  Millions$ 18  Millions
Sharps Technology Inc   4.12 $ 3.585  Millions$ 1  Millions
Coherus Oncology inc   4.11 $ 14.975  Millions$ 4  Millions
Novocure Limited  4.08 $ 167.287  Millions$ 41  Millions
Lifeward ltd   4.08 $ 13.275  Millions$ 3  Millions
Ge Healthcare Technologies Inc   4.04 $ 9,262.000  Millions$ 2,294  Millions
Koru Medical Systems Inc   3.99 $ 16.468  Millions$ 4  Millions
3m Company  3.94 $ 15,087.000  Millions$ 3,830  Millions
Iridex Corp  3.92 $ 32.247  Millions$ 8  Millions

Date modified: 2026-08-29T17:45:08+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.